BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27221887)

  • 41. Diagnostic utility of dual fusion PML/RARalpha translocation DNA probe (D-FISH) in acute promyelocytic leukemia.
    Wan TS; So CC; Hui KC; Yip SF; Ma ES; Chan LC
    Oncol Rep; 2007 Apr; 17(4):799-805. PubMed ID: 17342318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance.
    Zayed A; Couban S; Hayne O; Sparavalo N; Shawwa A; Sadek I; Greer W
    Leuk Lymphoma; 2007 Mar; 48(3):489-96. PubMed ID: 17454588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
    Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
    Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of PML/RARalpha fusion gene transcripts that showed no t(15;17) with conventional karyotyping and fluorescent in situ hybridization.
    Choughule A; Polampalli S; Amre P; Shinde S; Banavali S; Prabhash K; Nair R; Subramanian PG; Gujral S; Parikh PM
    Genet Mol Res; 2009 Jan; 8(1):1-7. PubMed ID: 19224461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytogenetic, fluorescent in situ hybridization & reverse transcriptase-polymerase chain reaction analysis in acute promyelocytic leukaemia patients.
    Shivakumar S; Poonkhuzhali B; Gunasekaran S; Srivastava A; Chandy M
    Indian J Med Res; 2002 Feb; 115():59-67. PubMed ID: 12138666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current treatment of acute promyelocytic leukemia.
    Lo Coco F; Ammatuna E; Sanz MA
    Haematologica; 2007 Mar; 92(3):289-91. PubMed ID: 17339175
    [No Abstract]   [Full Text] [Related]  

  • 49. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characterization of der(15)t(11;15) as a secondary cytogenetic abnormality in acute promyelocytic leukemia with cryptic PML-RAR alpha fusion on 17q.
    Wan TS; Ma SK; Yip SF; Yeung YM; Chan LC
    Cancer Genet Cytogenet; 2000 Aug; 121(1):90-3. PubMed ID: 10958948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
    Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
    Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
    Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
    Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies".
    Grimwade D; Biondi A; Mozziconacci MJ; Hagemeijer A; Berger R; Neat M; Howe K; Dastugue N; Jansen J; Radford-Weiss I; Lo Coco F; Lessard M; Hernandez JM; Delabesse E; Head D; Liso V; Sainty D; Flandrin G; Solomon E; Birg F; Lafage-Pochitaloff M
    Blood; 2000 Aug; 96(4):1297-308. PubMed ID: 10942371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.
    Han JY; Kim KE; Kim KH; Park JI; Kim JS
    Leuk Res; 2007 Feb; 31(2):239-43. PubMed ID: 16797070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined cytogenetic, FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission.
    Mancini M; Nanni M; Cedrone M; Diverio D; Avvisati G; Riccioni R; De Cuia MR; Fenu S; Alimena G
    Br J Haematol; 1995 Dec; 91(4):878-84. PubMed ID: 8547133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoderivative chromosome 17 with multiple copies of RARα-PML fusions and Tp53 deletion in a rare case of APML.
    Shetty D; Talker E; Sengar M; Subramanian PG
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):248-250. PubMed ID: 30981688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.